Immulite Carbamazepine, Immulite 2000 Carbamazepine, Catalog # LKCB1, LKCB5 & L2KCB2, L2KCB6
510(k) K000007
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK000007 | Date28 Feb 2000 | StatusActive |
Recalls
No FDA recalls found in the data synced 6 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- KLT
- Device Class
- Class II
- Regulation
- 21 CFR Part 862.3645
- Advisory Committee
- Clinical Toxicology
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 23 Sep 2026
The Immulite Carbamazepine is an enzyme immunoassay device used for the quantitative determination of carbamazepine in human serum and plasma. It is designed to assist in the monitoring of therapeutic drug levels for patients treated with carbamazepine.
This device is supplied as a single-use product and is intended for laboratory use only. It is regulated under FDA 510K clearance with device class II and product code KLT. The device is available in catalog numbers LKCB1, LKCB5, L2KCB2, and L2KCB6.
Other devices from Diagnostic Products Corp.
Questions
AI-generated answers, 23 Sep 2026
What is the Immulite Carbamazepine device used for?
The Immulite Carbamazepine is an enzyme immunoassay device used for the quantitative determination of carbamazepine in human serum and plasma. It is designed to assist in monitoring therapeutic drug levels for patients treated with carbamazepine.
How is the Immulite Carbamazepine supplied and what are its catalog numbers?
The device is supplied as a single-use product and is intended for laboratory use only. It is available in catalog numbers LKCB1, LKCB5, L2KCB2, and L2KCB6.
What is the regulatory status of the Immulite Carbamazepine device?
The device is regulated under FDA 510K clearance with device class II and product code KLT. It was received by the FDA on January 3, 2000, and cleared on February 28, 2000, with decision code SESE indicating substantial equivalence.
What is the manufacturer of the Immulite Carbamazepine device?
The Immulite Carbamazepine device is manufactured by Diagnostic Products Corp., located at 5700 W. 96th St., Los Angeles, CA 90045.